Myrexis Inc – Confidential Settlement Agreement, Including Releases of Claims, Covenant Not to Sue, and Stipulation of Dismissial (February 8th, 2013)
This Settlement Agreement, including Releases of Claims, Covenant Not To Sue, and Stipulation of Dismissal of the Litigation (as defined below) (the Agreement), is made and entered into as of December 20, 2012, between and among Alzheimers Institute of America, Inc. (AIA), and Myrexis, Inc. (Myrexis), Myriad Genetics, Inc. (Myriad Genetics), Myriad Therapeutics, Inc. (formerly known as Myriad Pharmaceuticals, Inc. and referred to herein as Myriad Pharmaceuticals), Mayo Clinic Jacksonville (Mayo Clinic) and Mayo Foundation for Medical Education and Research (Mayo Foundation). The foregoing entities are collectively referred to herein as the Parties, or individually referred to as a Party; Myriad Genetics and Myriad Pharmaceuticals are collectively referred to herein as Myriad; Mayo Clinic and Mayo Foundation are collectively referred to herein as Mayo; and Myrexis, Myriad Genetics, Myriad Pharmaceuticals, Mayo Clinic and Mayo Foundation are collectively are referred to herein as the Pla
Myrexis Inc – MYREXIS, INC. Executive Severance and Consulting Agreement (January 28th, 2013)
THIS EXECUTIVE SEVERANCE AND CONSULTING AGREEMENT (this "Agreement"), by and between Myrexis, Inc., a Delaware corporation (the "Company"), and Andrea Kendell (the "Executive"), is made as of January 22. 2013.
Myrexis Inc – First Amendment to Shareholder Rights Agreement Between Myrexis, Inc. And American Stock Transfer & Trust Company, Llc (March 30th, 2012)
This First Amendment to Shareholder Rights Agreement (the Amendment) is made as of this 29th day of March, 2012 by and between Myrexis, Inc. (f/k/a Myriad Pharmaceuticals, Inc.), a Delaware corporation (the Company), and American Stock Transfer & Trust Company, LLC, as rights agent (the Rights Agent). Capitalized terms used but not defined herein shall have the meanings given to such terms in the Rights Agreement (as defined below).
Myrexis Inc – MYREXIS, INC. Executive Severance and Change in Control Agreement (September 28th, 2011)
THIS EXECUTIVE SEVERANCE AND CHANGE IN CONTROL AGREEMENT (this Agreement), by and between Myrexis, Inc., a Delaware corporation (the Company), and Andrea Kendell (the Executive), is made as of September 22, 2011 (the Effective Date).
Myrexis Inc – September 22, 2011 Andrea Kendell [ADDRESS] Dear Andrea: (September 28th, 2011)
The Board of Directors (the Board) of Myrexis, Inc. (the Company) is pleased to offer you the position of Chief Financial Officer (the Offer). You will be expected to perform various duties consistent with this position, and you will report directly to the Chief Executive Officer. This Offer is conditioned on your acceptance of the terms set forth below in this letter (this Offer Letter).